{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:40:30Z","timestamp":1782740430206,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T00:00:00Z","timestamp":1457049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s13730-016-0214-5","type":"journal-article","created":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T06:01:04Z","timestamp":1457071264000},"page":"148-153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Five-year follow-up of a case of lipoprotein glomerulopathy with APOE Kyoto mutation"],"prefix":"10.1007","volume":"5","author":[{"given":"Ryosuke","family":"Usui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosaku","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,4]]},"reference":[{"key":"214_CR1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0272-6386(89)80134-9","volume":"13","author":"T Saito","year":"1989","unstructured":"Saito T, Sato H, Kudo K, et al. Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. Am J Kidney Dis. 1989;13:148\u201353.","journal-title":"Am J Kidney Dis"},{"key":"214_CR2","doi-asserted-by":"crossref","first-page":"31269","DOI":"10.1074\/jbc.M005906200","volume":"275","author":"Y Ishigaki","year":"2000","unstructured":"Ishigaki Y, Oikawa S, Suzuki T, et al. Virus-mediated transduction of apolipoprotein E (ApoE)-sendai develops lipoprotein glomerulopathy in ApoE-deficient mice. J Biol Chem. 2000;275:31269\u201373.","journal-title":"J Biol Chem"},{"key":"214_CR3","doi-asserted-by":"crossref","first-page":"9311","DOI":"10.1186\/1752-1947-3-9311","volume":"3","author":"G Russi","year":"2009","unstructured":"Russi G, Furci L, Leonelli M, et al. Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report. J Med Case Rep. 2009;3:9311.","journal-title":"J Med Case Rep"},{"key":"214_CR4","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/ndt\/gfn555","volume":"24","author":"Z Xin","year":"2009","unstructured":"Xin Z, Zhihong L, Shijun L, et al. Successful treatment of patients with lipoprotein glomerulopathy by protein A immunoadsorption: a pilot study. Nephrol Dial Transplant. 2009;24:864\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"214_CR5","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/jhg.2013.8","volume":"58","author":"K Toyota","year":"2013","unstructured":"Toyota K, Hashimoto T, Ogino D, et al. A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy. J Hum Genet. 2013;58:254\u20138.","journal-title":"J Hum Genet"},{"key":"214_CR6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ki.2013.335","volume":"85","author":"Z Hu","year":"2014","unstructured":"Hu Z, Huang S, Wu Y, et al. Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation. Kidney Int. 2014;85:416\u201324.","journal-title":"Kidney Int"},{"key":"214_CR7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s10157-009-0195-1","volume":"13","author":"A Ishimura","year":"2009","unstructured":"Ishimura A, Watanabe M, Nakashima H, et al. Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice. Clin Exp Nephrol. 2009;13:430\u20137.","journal-title":"Clin Exp Nephrol"},{"key":"214_CR8","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/ndt\/12.11.2442","volume":"11","author":"PA Andrews","year":"1997","unstructured":"Andrews PA, O\u2019Donnell PJ, Dilly SA, Snowden SA, Bewick M. Recurrence of lipoprotein glomerulopathy after renal transplantation. Nephrol Dial Transplant. 1997;11:2442\u20134.","journal-title":"Nephrol Dial Transplant"},{"key":"214_CR9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1442-200x.2001.01344.x","volume":"43","author":"M Shimizu","year":"2001","unstructured":"Shimizu M, Ohno T, Kimoto H, Hosono S, Nozawa M. A newborn infant with lipoprotein glomerulopathy associated with congenital nephrotic syndrome. Pediatr Int. 2001;43:78\u201380.","journal-title":"Pediatr Int"},{"key":"214_CR10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1523-1755.1999.00572.x","volume":"56","author":"A Matsunaga","year":"1999","unstructured":"Matsunaga A, Sasaki J, Komatsu T, et al. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy. Kidney Int. 1999;56:421\u20137.","journal-title":"Kidney Int"},{"key":"214_CR11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.3513311","volume":"232","author":"MS Brown","year":"1986","unstructured":"Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34\u201347.","journal-title":"Science"},{"key":"214_CR12","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.embor.7401103","volume":"8","author":"R Usui","year":"2007","unstructured":"Usui R, Shibuya M, Ishibashi S, Maru Y. Ligand-independent activation of vascular endothelial growth factor receptor 1 by low-density lipoprotein. EMBO Rep. 2007;8:1155\u201361.","journal-title":"EMBO Rep"},{"key":"214_CR13","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/sj.emboj.7601082","volume":"25","author":"C Cao","year":"2006","unstructured":"Cao C, Lawrence DA, Li Y, et al. Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration. EMBO J. 2006;25:1860\u201370.","journal-title":"EMBO J"},{"key":"214_CR14","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/01.ASN.0000015615.14428.67","volume":"13","author":"Y Kanamaru","year":"2002","unstructured":"Kanamaru Y, Nakao A, Shirato I, et al. Chronic graft-versus-host autoimmune disease in Fc receptor gamma chain-deficient mice results in lipoprotein glomerulopathy. J Am Soc Nephrol. 2002;13:1527\u201333.","journal-title":"J Am Soc Nephrol"},{"key":"214_CR15","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1093\/ndt\/gfs329","volume":"27","author":"K Ito","year":"2012","unstructured":"Ito K, Nakashima H, Watanabe M, Ishimura A, et al. Macrophage impairment produced by Fc receptor gamma deficiency plays a principal role in the development of lipoprotein glomerulopathy in concert with apoE abnormalities. Nephrol Dial Transplant. 2012;27:3899\u2013907.","journal-title":"Nephrol Dial Transplant"},{"key":"214_CR16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.ajkd.2005.10.017","volume":"47","author":"T Saito","year":"2006","unstructured":"Saito T, Matsunaga A, Oikawa S. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Am J Kidney Dis. 2006;47:199\u2013211.","journal-title":"Am J Kidney Dis"},{"key":"214_CR17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10157-009-0207-1","volume":"13","author":"A Matsunaga","year":"2009","unstructured":"Matsunaga A, Furuyama M, Hashimoto T, et al. Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy. Clin Exp Nephrol. 2009;13:659\u201362.","journal-title":"Clin Exp Nephrol"},{"key":"214_CR18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/ajkd.2003.50016","volume":"41","author":"N Ieiri","year":"2003","unstructured":"Ieiri N, Hotta O, Taguma Y. Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy. Am J Kidney Dis. 2003;41:244\u20139.","journal-title":"Am J Kidney Dis"},{"key":"214_CR19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0021-9150(03)00194-1","volume":"169","author":"T Arai","year":"2003","unstructured":"Arai T, Yamashita S, Yamane M, et al. Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy. Atherosclerosis. 2003;169:293\u20139.","journal-title":"Atherosclerosis"},{"key":"214_CR20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/ndt\/gfm675","volume":"23","author":"M Kinomura","year":"2008","unstructured":"Kinomura M, Sugiyama H, Saito T, et al. A novel variant apolipoprotein E Okayama in a patient with lipoprotein glomerulopathy. Nephrol Dial Transplant. 2008;23:751\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"214_CR21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5414\/CN106876","volume":"78","author":"MT Liao","year":"2012","unstructured":"Liao MT, Tsai IJ, Cheng HT, et al. A rare cause of childhood-onset nephrotic syndrome: lipoprotein glomerulopathy. Clin Nephrol. 2012;78:237\u201340.","journal-title":"Clin Nephrol"},{"key":"214_CR22","doi-asserted-by":"crossref","first-page":"536","DOI":"10.5551\/jat.8102","volume":"18","author":"T Tokura","year":"2011","unstructured":"Tokura T, Itano S, Kobayashi S, Kuwabara A, Fujimoto S, Horike H, Satoh M, Komai N, Tomita N, Matsunaga A, Saito T, Sasaki T, Kashihara N. A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy. J Atheroscler Thromb. 2011;18:536\u201341.","journal-title":"J Atheroscler Thromb"},{"key":"214_CR23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10157-010-0333-9","volume":"14","author":"H Hamatani","year":"2010","unstructured":"Hamatani H, Hiromura K, Kobatake K, et al. Successful treatment of lipoprotein glomerulopathy in a daughter and a mother using niceritrol. Clin Exp Nephrol. 2010;14:619\u201324.","journal-title":"Clin Exp Nephrol"},{"key":"214_CR24","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/ki.2011.17","volume":"79","author":"Y Zhou","year":"2011","unstructured":"Zhou Y, Kong X, Zhao P, et al. Peroxisome proliferator-activated receptor-\u03b1 is renoprotective in doxorubicin-induced glomerular injury. Kidney Int. 2011;79:1302\u201311.","journal-title":"Kidney Int"},{"key":"214_CR25","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/sj.ki.5000209","volume":"69","author":"CW Park","year":"2006","unstructured":"Park CW, Zhang Y, Zhang X, et al. PPARalpha agonist fenofibrate improves diabetic nephropathy in db\/db mice. Kidney Int. 2006;69:1511\u20137.","journal-title":"Kidney Int"},{"key":"214_CR26","doi-asserted-by":"crossref","first-page":"F328","DOI":"10.1152\/ajprenal.00484.2007","volume":"296","author":"K Kono","year":"2009","unstructured":"Kono K, Kamijo Y, Hora K, et al. PPAR\u03b1 attenuates the proinflammatory response in activated mesangial cells. Am J Physiol Renal Physiol. 2009;296:F328\u201336.","journal-title":"Am J Physiol Renal Physiol"},{"key":"214_CR27","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/ki.2010.530","volume":"79","author":"Y Tanaka","year":"2011","unstructured":"Tanaka Y, Kume S, Araki S, et al. Fenofibrate, a PPAR\u03b1 agonist, has renoprotective effects in mice by enhancing renal lipolysis. Kidney Int. 2011;79:871\u201382.","journal-title":"Kidney Int"},{"key":"214_CR28","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/ki.1993.388","volume":"44","author":"Y Nishizawa","year":"1993","unstructured":"Nishizawa Y, Shoji T, Nishitani H, et al. Hypertriglyceridemia and lowered apolipoprotein C-II\/C-III ratio in uremia: effect of a fibric acid, clinofibrate. Kidney Int. 1993;44:1352\u20139.","journal-title":"Kidney Int"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-016-0214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-016-0214-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-016-0214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-016-0214-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T12:44:59Z","timestamp":1559479499000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-016-0214-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["214"],"URL":"https:\/\/doi.org\/10.1007\/s13730-016-0214-5","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,4]]}}}